Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jessica Keim-Malpass & H Charles Malpass. (2022) Cost Utility of Bronchial Thermoplasty for Severe Asthma: Implications for Future Cost-Effectiveness Analyses Based on Phenotypic Heterogeneity. ClinicoEconomics and Outcomes Research 14, pages 427-437.
Read now
Read now
Articles from other publishers (14)
Qiuling Zhao, Ruixiang Xie, Wanfu Zhong, Wenbin Liu, Ting Chen, Xiuliang Qiu & Lin Yang. (2023) Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Crossref
Rachel M. Townsley, Priscille R. Koutouan, Maria E. Mayorga, Sarah D. Mills, Melinda M. Davis & Kristen Hasmiller Lich. (2022) When History and Heterogeneity Matter: A Tutorial on the Impact of Markov Model Specifications in the Context of Colorectal Cancer Screening. Medical Decision Making 42:7, pages 845-860.
Crossref
Crossref
Fang Chen, Carolyn B. Jasik, Timothy M. Dall & Cynthia Veronica Siego. (2022) Impact of a Digitally Enhanced Diabetes Self-Management Program on Glycemia and Medical Costs. The Science of Diabetes Self-Management and Care 48:4, pages 258-269.
Crossref
Crossref
Ting Chen, Ruixiang Xie, Qiuling Zhao, Hongfu Cai & Lin Yang. (2022) Cost-Utility Analysis of Camrelizumab Plus Chemotherapy Versus Chemotherapy Alone as a First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer in China. Frontiers in Oncology 12.
Crossref
Crossref
Vinayak Bhardwaj, Erin M. Spaulding, Francoise A. Marvel, Sarah LaFave, Jeffrey Yu, Daniel Mota, Ting-Jia Lorigiano, Pauline P. Huynh, Rongzi Shan, Pooja S. Yesantharao, Matthias A. Lee, William E. Yang, Ryan Demo, Jie Ding, Jane Wang, Helen Xun, Lochan Shah, Daniel Weng, Shannon Wongvibulsin, Jocelyn Carter, Julie Sheidy, Renee McLin, Jennifer Flowers, Maulik Majmudar, Eric Elgin, Valerie Vilarino, David Lumelsky, Curtis Leung, Jerilyn K. Allen, Seth S. Martin & William V. Padula. (2021) Cost-effectiveness of a Digital Health Intervention for Acute Myocardial Infarction Recovery. Medical Care 59:11, pages 1023-1030.
Crossref
Crossref
Tushar Srivastava, Nicholas R. Latimer & Paul Tappenden. (2021) Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals. PharmacoEconomics 39:8, pages 869-878.
Crossref
Crossref
Kunxi Bao, Xiaobing Li, Xiaojing He & Lingyan Jian. (2021) Pharmacoeconomic Evaluation of Erlotinib for the Treatment of Pancreatic Cancer. Clinical Therapeutics 43:6, pages 1107-1115.
Crossref
Crossref
Patricia J. Rodriguez, Zachary J. Ward, Michael W. Long, S. Bryn Austin & Davene R. Wright. (2021) Applied Methods for Estimating Transition Probabilities from Electronic Health Record Data. Medical Decision Making 41:2, pages 143-152.
Crossref
Crossref
Zoltán Vokó, István Bitter, Beatrix Mersich, János Réthelyi, Anett Molnár, János G. Pitter, Árpád Götze, Margit Horváth, Kristóf Kóczián, Laura Fonticoli, Filippo Lelli & Bertalan Németh. (2020) Using informative prior based on expert opinion in Bayesian estimation of the transition probability matrix in Markov modelling—an example from the cost-effectiveness analysis of the treatment of patients with predominantly negative symptoms of schizophrenia with cariprazine. Cost Effectiveness and Resource Allocation 18:1.
Crossref
Crossref
Radhika P. Tampi, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Sally She‐Ting Shu, Henry Lik‐Yuen Chan, James Fung, Maria Stepanova & Zobair M. Younossi. (2020) Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong. Hepatology Research 50:9, pages 1024-1031.
Crossref
Crossref
T. Sharma. (2020) Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults. Public Health 182, pages 70-76.
Crossref
Crossref
Stella T. Lartey, Lei Si, Petr Otahal, Barbara de Graaff, Godfred O. Boateng, Richard Berko Biritwum, Nadia Minicuci, Paul Kowal, Costan G. Magnussen & Andrew J. Palmer. (2020) Annual transition probabilities of overweight and obesity in older adults: Evidence from World Health Organization Study on global AGEing and adult health. Social Science & Medicine 247, pages 112821.
Crossref
Crossref
Zobair M. Younossi, Radhika Tampi, Massoom Priyadarshini, Fatema Nader, Issah M. Younossi & Andrei Racila. (2019) Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States. Hepatology 69:2, pages 564-572.
Crossref
Crossref
Juliana Yukari Kodaira Viscondi, Christine Grutzmann Faustino, Alessandro Gonçalves Campolina, Alexander Itria & Patricia Coelho de Soárez. (2018) Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening. Clinics 73, pages e385.
Crossref
Crossref